Agios Pharmaceuticals, Inc. (AGIO)
27.01
+0.07
(+0.26%)
USD |
NASDAQ |
Feb 10, 14:05
Agios Pharmaceuticals EPS Diluted (Quarterly) : -1.779 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| CorMedix, Inc. | 1.259 |
| Gilead Sciences, Inc. | 2.434 |
| Fulcrum Therapeutics, Inc. | -0.313 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -103.43M |
| Revenue (Quarterly) | 12.88M |
| Total Expenses (Quarterly) | 116.31M |
| Enterprise Value | 662.63M |
| Gross Profit Margin (Quarterly) | 76.30% |
| Profit Margin (Quarterly) | -803.1% |
| Earnings Yield | -25.75% |
| Normalized Earnings Yield | -25.75 |